JOHN DONOFRIO, JR.

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

AYTU BIOPHARMA, INC

Filing Date Source Excerpt
2021-04-19 "...including consolidated financial reporting, international accounting and internal controls, financial systems development and implementation..."

Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-04-09